T2 Biosystems, Inc. financial data

Location
Lexington, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 14 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 40% % -37%
Quick Ratio 12% % -2.3%
Debt-to-equity -219% % -8.7%
Return On Equity 206% % 50%
Return On Assets -173% % -28%
Operating Margin -543% % -20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21,042,952 shares 420%
Common Stock, Shares, Outstanding 18,760,092 shares 379%
Common Stock, Value, Issued $18,000 USD 350%
Weighted Average Number of Shares Outstanding, Basic 17,892,606 shares 300%
Weighted Average Number of Shares Outstanding, Diluted 17,892,606 shares 300%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $7,677,000 USD -30%
Research and Development Expense $12,918,000 USD -17%
Costs and Expenses $49,332,000 USD -19%
Operating Income (Loss) $41,655,000 USD 16%
Nonoperating Income (Expense) $1,299,000 USD -4579%
Net Income (Loss) Attributable to Parent $42,954,000 USD 14%
Earnings Per Share, Basic 120 USD/shares 83%
Earnings Per Share, Diluted 120 USD/shares 83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,083,000 USD -91%
Accounts Receivable, after Allowance for Credit Loss, Current $2,033,000 USD 78%
Inventory, Net $3,825,000 USD -11%
Assets, Current $9,786,000 USD -70%
Property, Plant and Equipment, Net $1,477,000 USD -28%
Operating Lease, Right-of-Use Asset $6,268,000 USD -19%
Other Assets, Noncurrent $1,000 USD -98%
Assets $18,082,000 USD -58%
Accounts Payable, Current $4,210,000 USD 287%
Employee-related Liabilities, Current $3,412,000 USD 5.6%
Accrued Liabilities, Current $4,627,000 USD -6.6%
Contract with Customer, Liability, Current $233,000 USD -16%
Liabilities, Current $24,435,000 USD -56%
Contract with Customer, Liability, Noncurrent $59,000 USD 48%
Operating Lease, Liability, Noncurrent $5,298,000 USD -25%
Liabilities $29,792,000 USD -52%
Retained Earnings (Accumulated Deficit) $616,910,000 USD -7.5%
Stockholders' Equity Attributable to Parent $11,710,000 USD 39%
Liabilities and Equity $18,082,000 USD -58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $11,683,000 USD 9.7%
Net Cash Provided by (Used in) Financing Activities $2,202,000 USD -81%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 18,760,092 shares 379%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,481,000 USD -682%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,600,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $839,000 USD -17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $45,646,000 USD 28%
Property, Plant and Equipment, Gross $16,481,000 USD -2.5%
Operating Lease, Liability, Current $1,724,000 USD 11%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares -100%
Depreciation, Depletion and Amortization $64,000 USD -75%
Share-based Payment Arrangement, Expense $2,802,000 USD -39%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%